Amiodarone-Associated Optic Neuropathy: Clinical Review.
Neuroophthalmology
; 41(2): 55-58, 2017 Apr.
Article
em En
| MEDLINE
| ID: mdl-28348626
ABSTRACT
Amiodarone, an antiarrhythmic agent, has been associated with visual loss secondary to optic neuropathy. The reported mean duration of amiodarone use before visual loss is about 9 months. Patients receiving amiodarone have a 2-fold increased risk of developing optic neuropathy, especially in males and possibly in patients with longer duration of treatment. Amiodarone-associated optic neuropathy is characterised by an insidious onset, slow progression, bilateral simultaneous visual loss, and protracted disc swelling. After discontinuing amiodarone use, visual acuity and visual field deficits tend to improve or stabilise in most patients, with about 20% of the patients getting worse.
Texto completo:
1
Coleções:
01-internacional
Base de dados:
MEDLINE
Tipo de estudo:
Risk_factors_studies
Idioma:
En
Revista:
Neuroophthalmology
Ano de publicação:
2017
Tipo de documento:
Article
País de afiliação:
Taiwan